Open AccessP564: FINAL RESULTS OF THE QOLESS AZA‐AMLE RANDOMIZED TRIAL TO EVALUATE THE EFFICACY OF 5‐AZA FOR POST‐REMISSION THERAPY OF ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS
Author(s) -
Oliva E. N.,
Salutari P.,
Di Raimondo F.,
Reda G.,
Capelli D.,
Iannì G.,
Tripepi G.,
Alati C.,
Mammì C.,
D'Errigo M. G.,
Niscola P.,
Selleri C.,
Musto P.,
Vigna E.,
Volpe A.,
Cascavilla N.,
Cannatà M. C.,
Mannina D.,
Candoni A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845144.35757.26
Subject(s) - medicine , cytarabine , clinical endpoint , randomized controlled trial , myeloid leukemia , placebo , chemotherapy , transplantation , azacitidine , surgery , biochemistry , gene expression , chemistry , alternative medicine , pathology , dna methylation , gene